Chris Exley Publications

Books

(1) Authored books

(2) Edited collection

  1. EXLEY C (Editor) (2001) Aluminium and Alzheimer's Disease: The Science that Describes the Link. Elsevier Science, Amsterdam, The Netherlands. 441p.

(3) Chapters in books

  1. EXLEY C & PHILLIPS MJ (1988) Acid rain: Implications for the farming of salmonids. In: (MUIR JF & ROBERTS RJ) (Eds) Recent Advances in Aquaculture, Volume 3 (Croom Helm, London) pp. 225-341.
  2. EXLEY C, BURGESS E, DAY JP, JEFFERY EH, MELETHIL S & YOKEL RA (1997) Aluminium toxicokinetics. In: RA YOKEL & MS GOLUB (Eds) Research Issues in Aluminium Toxicity (Taylor & Francis, Washington DC, USA) pp. 117-132.
  3. HARRIS WR, BERTHON G, DAY JP, EXLEY C, FLATEN TP, FORBES WF, KISS T, ORVIG C & ZATTA PF (1997) Speciation of aluminium in biological systems. In: RA YOKEL & MS GOLUB (Eds) Research Issues in Aluminium Toxicity (Taylor & Francis, Washington DC, USA) pp. 91-116.
  4. SAVORY J, EXLEY C, FORBES WF, HUANG Y, JOSHI JG, KRUCK T, MCLACHLAN DRC & WAKAYAMA I (1996) Can the controversy of the role of aluminium in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? In: RA YOKEL & MS GOLUB (Eds) Research Issues in Aluminium Toxicity (Taylor & Francis, Washington DC, USA) pp. 185-206.
  5. EXLEY C (2001) Preface. Why is research into aluminium and life important? In: EXLEY C (Ed) Aluminium and Alzheimer's Disease: The Science that Describes the Link (Elsevier Science, Amsterdam, The Netherlands) pp. V-VIII.
  6. EXLEY C & KORCHAZHKINA O (2001) The association of aluminium and beta amyloid in Alzheimer's disease. In: Aluminium and Alzheimer's Disease: The Science that Describes the Link. Elsevier Science, Amsterdam, The Netherlands. pp. 421-433.
  7. EXLEY C (2005) The Aluminium-Amyloid Cascade Hypothesis and Alzheimer's Disease. In: Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta. Subcellular Biochemistry 38, (Eds. Harris R & Fahrenholz F) pp. 225-234.
  8. EXLEY C (2007) The solubility of hydroxyaluminosilicates and the biological availability of aluminium. In: Thermodynamics, Solubility and Environmental Issues (Ed. Letcher TM), Elsevier Science, Amsterdam, The Netherlands. pp. 315-325.
  9. EXLEY C (2009) Aluminium and Medicine. In; Molecular and Supramolecular Bioinorganic Chemistry: Applications in Medical Sciences. (Ed. ALR Merce, J Felcman, MAL Recio), Nova Science Publishers Inc. New York, pp. 45-68.
  10. EXLEY C (2009) Silicon in Life: Whither Biological Silicifcation? In; Biosilica in Evolution, Morphogenesis, and Nanobiotechnology (Eds. WEG Müller, MA Grachev), Progress in Molecular and Subcellular Biology, Marine Molecular Biotechnology, 47, pp. 173-184.
  11. EXLEY C and HOUSE ER (2012) Aluminium in the human brain. In: Metal Ions in Neurological Systems (Linert W. & Kozlowski H. Eds) Springer pp. 95-102.
  12. Exley C (2012) Aluminium in biological systems. Encyclopedia of Metalloproteins (Kretsinger RH, Permyakov EA, Uversky VN eds.) Springer Science (In the press).

Articles

(1) Peer reviewed journals

  1. BIRCHALL JD, EXLEY C, CHAPPELL JS & PHILLIPS MJ (1989) Acute toxicity of aluminium to fish eliminated in silicon-rich acid waters. Nature, 338, pp. 146-148.
  2. BIRCHALL JD, EXLEY C & CHAPPELL JS (1989) Silicon in natural waters and the bioavailability of aluminium. Journal of Inorganic Biochemistry, 36, pp. 317.
  3. EXLEY C, CHAPPELL JS & BIRCHALL JD (1991) A mechanism for acute aluminium toxicity in fish. Journal of Theoretical Biology, 151, pp. 417-428.
  4. BIRCHALL JD & EXLEY C (1992) Silicon and the bioavailability of aluminium. Metal Compounds in Environment and Life,4, pp. 411-418.
  5. EXLEY C & BIRCHALL JD (1992) Hydroxyaluminosilicate formation in solutions of low total aluminium concentration. Polyhedron, 11, pp. 1901-1907.
  6. EXLEY C & STRUTHERS W (1992) The localisation of aluminium in the tissues of the rainbow trout. Aquaculture, 100, pp. 323-324.
  7. EXLEY C & BIRCHALL JD (1992) The cellular toxicity of aluminium. Journal of Theoretical Biology, 159, pp. 83-98.
  8. EXLEY C & BIRCHALL JD (1993) A mechanism of hydroxyaluminosilicate formation. Polyhedron, 12, 1007-1017.
  9. EXLEY C, TOLLERVEY A, GRAY G, ROBERTS S & BIRCHALL JD (1993) Silicon, aluminium and the biological availability of phosphorus in algae. Proceedings of the Royal Society of London Series B, 253, pp. 93-99.
  10. EXLEY C, PRICE NC, KELLY SM & BIRCHALL JD (1993) An interaction of beta-amyloid with aluminium in vitro. FEBS Letters 324, 293-295.
  11. EXLEY C & BIRCHALL JD (1993) Aluminium and Alzheimer's Disease. Age and Ageing, 22, pp. 391-392.
  12. EXLEY C, PRICE NC & BIRCHALL JD (1994) Aluminium inhibition of hexokinase activity in vitro: a study in biological availability. Journal of Inorganic Biochemistry 54, 297-304.
  13. EXLEY C, WICKS AJ, HUBERT RB & BIRCHALL JD (1994) Polynuclear aluminium and acute aluminium toxicity in the fish. Journal of Theoretical Biology, 167, pp. 415-416.
  14. EXLEY C & BIRCHALL JD (1995) Comment on "An assessment of complex formation between aluminium and silicic acid in acidic solutions". Geochimica Cosmochimica Acta 59, 5, 1017-1018.
  15. EXLEY C, SCHLEY L, MURRAY S, HACKNEY CM & BIRCHALL JD (1995) Aluminium, beta-amyloid and non-enzymatic glycosylation. FEBS Letters 364, 182-184.
  16. EXLEY C (1996) Aluminium in the brain and heart of the rainbow trout. Journal of Fish Biology 48, 706-713.
  17. EXLEY C & BIRCHALL JD (1996) Biological availability of aluminium in commercial ATP. Journal of Inorganic Biochemistry 63, 241-252.
  18. EXLEY C, WICKS AJ, HUBERT RB & BIRCHALL JD (1996) Kinetic constraints in acute aluminium toxicity in the rainbow trout (Oncorhynchus mykiss). Journal of Theoretical Biology 179, 25-31.
  19. EXLEY C, BURGESS E, DAY JP, JEFFERY EH, MELETHIL S & YOKEL RA (1996) Aluminium toxicokinetics. Journal of Toxicology and Environmental Health 48, 569-584.
  20. HARRIS WR, BERTHON G, DAY JP, EXLEY C, FLATEN TP, FORBES WF, KISS T, ORVIG C & ZATTA PF (1996) Speciation of aluminium in biological systems. Journal of Toxicology and Environmental Health 48, 543-568.
  21. SAVORY J, EXLEY C, FORBES WF, HUANG Y, JOSHI JG, KRUCK T, MCLACHLAN DRC & WAKAYAMA I (1996) Can the controversy of the role of aluminium in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? Journal of Toxicology  and Environmental Health 48, 615-635.
  22. EXLEY C & BIRCHALL JD (1996) Silicic acid and the biological availability of aluminium. European Journal of Soil Science, 47, pp. 137.
  23. EXLEY C (1996) In vitro toxicity of beta-amyloid. Biochemical Journal 314, 709.
  24. EXLEY C (1996) Amyloid, aluminium and the aetiology of Alzheimer's disease. Medical Journal of Australia, 164, pp. 252-253.
  25. EXLEY C (1996) Aluminium-containing DTP vaccines. The Lancet Infectious Diseases B, p. 324.
  26. EXLEY C (1997) ATP-promoted amyloidosis of an amyloid beta peptide. Neuroreport 8, 3411-3414.
  27. EXLEY C, PINNEGAR JK & TAYLOR H (1997) Hydroxyaluminosilicates and acute aluminium toxicity in fish. Journal of Theoretical Biology 189, 133-139.
  28. EXLEY C (1998) Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer's disease? Molecular Medicine Today 4, 107-109.
  29. EXLEY C (1998) Silicon in life: A bioinorganic solution to bioorganic essentiality. Journal of Inorganic Biochemistry 69, 139-144.
  30. KORCHAZHKINA O, WRIGHT G & EXLEY C (1998) Action of Al-ATP on the isolated working rat heart. Journal of Inorganic Biochemistry 69, 153-158.
  31. EXLEY C (1998) The precipitation of mucin by aluminium. Journal of Inorganic Biochemistry 70, 195-206.
  32. KORCHAZHKINA O, WRIGHT G & EXLEY C (1999) Intravascular ATP and coronary vasodilation in the isolated working rat heart. British Journal of Pharmacology 127, 701-708.
  33. EXLEY C (1999) A molecular mechanism of aluminium-induced Alzheimer's disease? Journal of Inorganic Biochemistry 76, 133-140.
  34. KORCHAZHKINA OV, WRIGHT G & EXLEY C (1999) No effect of aluminium upon the hydrolysis of ATP in the coronary circulation of the isolated working rat heart. Journal of Inorganic Biochemistry 76, 121-126
  35. EXLEY C (2000) Avoidance of aluminium by rainbow trout. Environmental Toxicology and Chemistry 19, 933-939
  36. DOUCET FJ, SCHNEIDER C, BONES SJ, KRETCHMER A, MOSS I, TEKELY P & EXLEY C (2001) The formation of hydroxyaluminosilicates of geochemical and biological significance. Geochimica Cosmochimica Acta 65, 2461-2467.
  37. EXLEY C & KORCHAZHKINA O (2001) Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (AlATP). Journal of Inorganic Biochemistry 84, 215-224.
  38. SCHNEIDER C & EXLEY C (2001) Silicic acid (Si(OH)4) is a significant influence upon the atomic absorption signal of aluminium measured by graphite furnace atomic absorption spectrometry (GFAAS). Journal of Inorganic Biochemistry 87, 45-50.
  39. DOUCET FJ, ROTOV ME & EXLEY C (2001) Direct and indirect identification of the formation of hydroxyaluminosilicates (HAS) in acidic solutions. Journal of Inorganic Biochemistry 87, 71-79.
  40. EXLEY C & KORCHAZHKINA OV (2001) Plasmin cleaves A[beta]42 in vitro and prevents its aggregation into b-pleated sheet structures. Neuroreport 12, 2967-2970.
  41. EXLEY C, SCHNEIDER C & DOUCET FJ (2002) The reaction of aluminium with silicic acid in acidic solution: An important mechanism in controlling the biological availability of aluminium? Coordination Chemistry Reviews, 228, pp. 127-135.
  42. KORCHAZHKINA OV, ASHCROFT AE, KISS T & EXLEY C (2002)The degradation of Ab25-35 by the serine protease plasmin is inhibited by aluminium. Journal of Alzheimer's Disease, 4, pp. 357-367.
  43. KORCHAZHKINA OV, ASHCROFT AE, CROOM J & EXLEY C (2003) Does either the gastrointestinal peptide PYY or the neuropeptide NPY bind aluminium? Journal of Inorganic Biochemistry, 94, pp. 372-380.
  44. KORCHAZHKINA OV, EXLEY C & SPENCER SA (2003) Measurement by RP- HPLC of malondialdehyde in normal human urine following derivitization with 2,4-dinitrophenylhydrazine. Journal of Chromatography B, 794, pp. 353-362.
  45. EXLEY C (2003) A biogeochemical cycle for aluminium? Journal of Inorganic Biochemistry, 97, pp. 1-7.
  46. EXLEY C (2004) The prooxidant activity of aluminium. Free Radical Biology and Medicine, 36, pp. 380-387.
  47. HOUSE E, COLLINGWOOD J, KHAN A, KORCHAZHKINA O, BERTHON G & EXLEY C (2004) Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of A[beta]42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. Journal of Alzheimers Disease 6, pp. 291-301. 
  48. KHAN A, ASHCROFT AE, KORCHAZHKINA OV & EXLEY C (2004) Metal-mediated formation of fibrillar ABri amyloid. Journal of Inorganic Biochemistry 98, PP. 2006-2010.
  49. SCHNEIDER C, DOUCET F, STREKOPYTOV S & EXLEY C (2004) The solubility of an hydroxy-aluminosilicate. Polyhedron 23, pp. 3185-3191.
  50. STREKOPYTOV S & EXLEY C (2005) The formation, precipitation and structural characterisation of hydroxyaluminosilicates formed in the presence of fluoride and phosphate. Polyhedron 24, pp. 1585-1592.
  51. EXLEY C (2005) Comment on "The biological behaviour and bioavailability of aluminium in man" by N.D. Priest, JEM, 2004, 6, 375. Journal of Environmental Monitoring 7, p. 640.
  52. EXLEY C, BEGUM A, WOOLLEY MP & BLOOR RN (2006) Aluminium in tobacco and cannabis and smoking-related disease. American Journal of Medicine 119, pp. 276.e9-276.ell.
  53. KHAN A, ASHCROFT AE, HIGENELL V, KORCHAZHKINA OV & EXLEY C (2005) Metals accelerate the formation and direct the structure of amyloid fibrils of NAC.  Journal of Inorganic Biochemistry 99, pp. 1920-1927.
  54. STREKOPYTOV S & EXLEY C (2006) Thermal analyses of aluminium hydroxide and hydroxyaluminosilicates. Polyhedron 25, pp. 1707-1713.
  55. EXLEY C, MAMUTSE G, KORCHAZHKINA O, PYE E, STREKOPYTOV S, POLWART A & HAWKINS C (2006) Elevated urinary excretion of aluminium and iron in multiple sclerosis. Multiple Sclerosis 12, pp. 533-540.
  56. KHAN A, DOBSON J & EXLEY C (2006) The redox cycling of iron by A[beta]42. Free Radical Biology and Medicine 40, pp. 557-569.
  57. EXLEY C & ESIRI M (2006) Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. Journal of Neurology Neurosurgery and Psychiatry  77, pp. 877-879.
  58. EXLEY C (2006) Aluminium and iron, but neither copper nor zinc, are key to the precipitation of [beta]-sheets of A[beta]42 in senile plaque cores in Alzheimer's disease. Journal of Alzheimer's Disease 10, pp. 173-177.
  59. EXLEY C (2006) Aluminium-adsorbed vaccines. The Lancet Infectious Diseases 6, p. 189.
  60. EXLEY C, BEARDMORE J & RUGG, G (2007) A computational approach to the blood-aluminium problem? International Journal of Quantum Chemistry 107, pp. 275-278.
  61. EXLEY C, KORCHAZHKINA O, JOB D, STREKOPYTOV S, POLWART A & CROME P (2006) Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease. Journal of Alzheimer's Disease 10, pp. 17-24.
  62. STREKOPYTOV S, JARRY E & EXLEY C (2006) Further insight into the mechanism of formation of hydroxyaluminosilicates. Polyhedron [1.843] 25, pp. 3399-3404.
  63. EXLEY C, AHMED U, POLWART A & BLOOR RN (2007) Elevated urinary aluminium in current and past users of illicit heroin. Addiction Biology 12, pp. 197-199.
  64. EXLEY C, CHARLES LM, BARR L, MARTIN C, POLWART A & DARBRE PD (2007) Aluminium in human breast tissue. Journal of Inorganic Biochemistry 101, pp. 1344-1346.
  65. BEARDMORE J, RUGG G & EXLEY C (2007) A systems biology approach to the blood-aluminium problem: The application and testing of a computational model. Journal of Inorganic Biochemistry 101, pp. 1187-1191.
  66. NICHOLSON S & EXLEY C (2007) Aluminium: A potential pro-oxidant in sunscreens/sunblocks? Free Radical Biology and Medicine 43, pp. 1216-1217.
  67. EXLEY C (2007) Aluminium, tau and Alzheimer's disease. Journal of Alzheimer's Disease 12, pp. 313-315.
  68. WARD B, WALKER K & EXLEY C (2008) Copper(II) inhibits the formation of amylin amyloid in vitro. Journal of Inorganic Biochemistry 102, pp. 371-375.
  69. MAINGON R, KHELA A, SAMPSON C, WARD R, WALKER K & EXLEY C (2008) Aluminium: a natural adjuvant in Leishmania transmission via sand flies? Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 1140-1142.
  70. EXLEY C, SWARBRICK L, GHERADI R & AUTHIER J-F (2009) A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Medical Hypotheses 72, 135-139.
  71. BEARDMORE J & EXLEY C (2009) Towards a model of non-equilibrium binding of metal ions in biological systems. Journal of Inorganic Biochemistry 103, 205-209.
  72. EXLEY C (2009) Silicon and bone. Bone 44, 1018.
  73. EXLEY C (2009) What happened to the epidemic in new variant Creutzfeldt-Jakob disease? Medical Hypotheses 72, 621-622.
  74. EXLEY C (2009) Darwin, natural selection and the biological essentiality of aluminium and silicon. Trends in Biochemical Sciences 34, 589-593.
  75. HOUSE E, MOLD M, COLLINGWOOD J, BALDWIN A, GOODWIN S & EXLEY C (2009) Copper abolishes the ?-sheet secondary structure of pre-formed amyloid fibrils of A?42. Journal of Alzheimer’s Disease 18, 811-817.
  76. EXLEY C, SIESJÖ P & ERIKSSON H (2010) The immunobiology of aluminium adjuvants: how do they really work? Trends in Immunology 31, 103-109.
  77. EXLEY C, HOUSE E, COLLINGWOOD JF, DAVIDSON M, CANNON D & DONALD AM (2010) Spherulites of A?42 in vitro and in Alzheimer’s disease. Journal of Alzheimer’s Disease 20, 1159-1165.
  78. EXLEY C, HOUSE E, PATEL T, WU L & FRASER PE (2010) Human pro-islet amyloid polypeptide (ProIAPP1-48) forms amyloid fibrils and amyloid spherulites in vitro. Journal of Inorganic Biochemistry 104, 1125-1129.
  79. BURRELL S-A M and EXLEY C (2010) There is (still) too much aluminium in infant formulas. BMC Pediatrics 10:63 doi:10.1186/1471-2431-10-63.
  80. EXLEY C and HOUSE E (2011) Aluminium in the human brain. Monatshefte für Chemie - Chemical Monthly 142, 357-363.
  81. HOUSE E, JONES K and EXLEY C (2011) Spherulites in human brain tissue are composed of beta sheets of amyloid and resemble senile plaques. Journal of Alzheimer’s Disease 25, 43-46.
  82. EXLEY C (2012) Reflections upon and recent insight into the mechanism of formation of hydroxyaluminosilicates and the therapeutic potential of silicic acid. Coordination Chemistry Reviews 256, 82-88.
  83. MUJIKA JI, RUIPEREZ F, INFANTE I, UGALDE JM, EXLEY C, LOPEZ X (2011) Pro-oxidant activity of aluminium: Stabilisation of the aluminium superoxide radical ion. The Journal of Physical Chemistry A 115, 6717-6723.
  84. LAW C and EXLEY C (2011) New insight into silica deposition in horsetail (Equisetum arvense). BMC Plant Biology 11, 112.
  85. EXLEY C (2012) Elucidating aluminium’s exposome. Current Inorganic Chemistry 2, 3-7.
  86. HOUSE E, ESIRI M, FORSTER G, INCE PG and EXLEY C (2012) Aluminium, iron and copper in human brain tissues donated to the medical research council’s cognitive function and ageing study. Metallomics 4, 56-65.
  87. EXLEY C (2011) Aluminium-based adjuvants should not be used as placebos in clinical trials. Vaccine 29, 9289.
  88. EXLEY C (2012) When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes. Vaccine 30, 2042.
  89. MOLD M, SHRIVE AK and EXLEY C (2012) Serum amyloid P component accelerates the formation and enhances the stability of amyloid fibrils in a physiologically significant under-saturated solution of A?42. Journal of Alzheimer’s Disease 29, 875-881.
  90. EXLEY C (2012) The coordination chemistry of aluminium in neurodegenerative disease. Coordination Chemistry Reviews 256, 2142-2146.
  91. EXLEY C, HOUSE E, POLWART A and ESIRI MM (2012) Brain burdens of aluminium, iron and copper and their relationships with amyloid beta pathology in 60 human brains. Journal of Alzheimer’s Disease 31, 725-730.
  92. EXLEY C, MOLD M, SHARDLOW E, SHUKER B, IKPE B, WU L and FRASER PE (2012) Copper is a potent inhibitor of the propensity for human ProIAPP1-48 to form amyloid fibrils in vitro. Journal of Diabetes Research and Clinical Medicine 1, 3 (26th May 2012).
  93. FOGLIO E, BUFFOLI B, EXLEY C, REZZANI R and RODELLA LF (2012) Regular consumption of a silicic acid-rich water prevents aluminium-induced alterations of nitrergic neurons in mouse brain: histochemical and immunohistochemical studies. Histology and Histopathology 27, 1055-1066.
  94. DAVENWARD S, BENTHAM P, WRIGHT J, CROME P, JOB, D, POLWART A and EXLEY C (2013) Silicon-rich mineral water as a non-invasive test of the ‘aluminium hypothesis’ in Alzheimer’s disease. Journal of Alzheimer’s Disease 33, 423-430.
  95. RUIPÉREZ F, MUJIKA JI, UGALDE JM, EXLEY C, LOPEZ X (2012) Pro-oxidant activity of aluminium: promoting the Fenton reaction by reducing Fe(III) to Fe(II). Journal of Inorganic Biochemistry 117, 118-123.
  96. Exley C and Mold MJ (2015) The binding, transport and fate of aluminium in biological cells. Journal of Trace Elements in Medicine and Biology 30, 90-95.
  97. Exley C, Rotheray E and Goulson D (2015) Bumblebee pupae contain high levels of aluminium. PLOS ONE 10 (6); e0127665. doi:10.1371/journal.pone.0127665.
  98. Exley C (2015) A possible mechanism of biological silicification in plants. Frontiers in Plant Science 6:853. doi: 10.3389/fpls.2015.00853.

(2) Other journal articles

  1. EXLEY C (1992) The Biological Chemistry of the Elements: The Inorganic Chemistry of Life. DA SILVA JJRF & RJP WILLIAMS (1991) Clarendon Press, Oxford. 561pp. In Trends in Biochemical Sciences, 17, p. 165. (Book Review)
  2. EXLEY C (1993) Black paper for science. Nature, 364, p. 276.
  3. EXLEY C & BIRCHALL JD (1995) Progress in aluminium toxicology and chemistry. First Keele Meeting on Aluminium. Biometals, 8, pp. 271-272. (Editorial)
  4. EXLEY C (1996) Dedication to Professor JD Birchall, OBE, FRS, 1930-1995. Journal of Toxicology and Environmental Health, 48, pp. v-vi.
  5. EXLEY C (1998) Guest Editorial. Aluminium and Silicon in Biology. JD Birchall Memorial Meeting. Second Keele Meeting on Aluminium, 24th - 26th February 1997. Journal of Inorganic Biochemistry, 69, p. 137.
  6. EXLEY C (1999) Guest Editorial. The Bioinorganic Chemistry of Aluminium: from Microbe to Man. Third Keele Meeting on Aluminium, 22nd - 24th February 1999. Journal of Inorganic Biochemistry, 76, p. 5.
  7. EXLEY C (2001) Guest Editorial. The Biological Availability of Aluminium: Sources, Sinks and Symptoms: Fourth Keele Meeting on Aluminium, 25-27th February 2001. Journal of Inorganic Biochemistry, 87, p. VII.
  8. EXLEY C (2001) Aluminium and Alzheimer's disease. Journal of Alzheimer's Disease, 3, pp. 551-552. (Invited Commentary)
  9. EXLEY C (2003) Guest Editorial. Aluminium in life: From acid rain to Alzheimer's disease. Fifth Keele Meeting on Aluminium, 23-25th February 2003. Journal of Inorganic Biochemistry 97, p. VII.
  10. EXLEY C (2004) Aluminum in antiperspirants: More than just skin deep. American Journal of Medicine 117, pp. 969-970.
  11. EXLEY (2005) Guest Editorial. Aluminium: Lithosphere to Biosphere (and Back). Sixth Keele Meeting on Aluminium, 26th February - 2nd March 2005. Journal of Inorganic Biochemistry 99, pp. 1747-1748.
  12. EXLEY C (2006) A vexing commentary on the important issue of aluminium and Alzheimer's disease. Journal of Alzheimer's Disease 10, pp. 451-452.
  13. EXLEY C (2006) Funding should recognize outcome, not income. Nature 440, p. 1112.
  14. EXLEY C (2007) Organosilicon therapy in Alzheimer's disease? Journal of Alzheimer's Disease 11, pp. 301-302.
  15. EXLEY C (2007) Guest Editorial. Life and Living in the Aluminium Age. Seventh Keele Meeting on Aluminium, 24-28th February 2007. Journal of Inorganic Biochemistry 101, pp. 1185-1186.
  16. EXLEY C (2008) Comment on “Avoidance of aluminium toxicity in freshwater snails involves intracellular silicon-aluminium biointeraction”. Environmental Science & Technology 42, 5374.